France· FR:67280591
INORIAL 2,5 mg/ml, solution buvable
A medicinal product containing bilastine, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BILASTINE
- Manufacturer
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301416251 bouteille(s) en verre jaune(brun) de 120 ml avec un système de fermeture inviolable ou avec fermeture de sécurité enfant avec gobelet(s) doseur(s) polypropylène
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bilastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBILAXTEN 2,5 MG/ML SOLUCION ORALFaes Farma S.A.
- CzechiaXADOSMenarini International Operations Luxembourg S.A., Luxembourg
- PolandBilaxtenMenarini International Operations Luxembourg S.A.
- IrelandDrynol 2.5 mg/ml oral solutionMenarini International Operations Luxembourg S.A.
- IcelandBilaxtenMenarini International Operations Luxembourg S.A.
- FinlandRevitelleMenarini International Operations Luxembourg S.A.
- BelgiumBellozal 2.5 mg/mlMenarini International Operations Luxembourg
- SwitzerlandAllerxtin Sandoz 20 mg, TablettenSandoz Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Bilastin Hyperpoll, Bilastin Tiefenbacher
- Belgium · Bellozal, Bilastine Ab
- Bulgaria · Bilastine Stada, Биластин Мсн
- Cyprus · Alivixa, Bilastine Delorbis
- Czechia · Abisax, Bilastin Stada
- Germany · Allegra Allergietabletten, Allegra Allergietabletten Kinder
- Denmark · Bilastine Stada, Revitelle
- Estonia · Bilastin, Bilastine Stada
- Spain · Abisax, Abrilia
- Finland · Bilastine Stada, Revitelle
- United Kingdom (Northern Ireland) · Bilastine Medreich, Bilastine Milpharm
- Greece · Bilargen, Bilastine Stada
- Croatia · Actine, Nixar
- Hungary · Bilastine Supremex, Bilastine Teva
- Ireland · Bilastine Clonmel, Bilhista
- Iceland · Bilaxten
- Italy · Alyne, Ayrinal
- Lithuania · Belargan, Bilastine Sandoz
- Luxembourg · Bellozal, Bilastine Eurogenerics
- Latvia · Bilastine Stada, Bilpexo
- Malta · Alivixa, Bilastine Clonmel
- Norway · Bilastine Stada, Zilas
- Poland · Adablix, Allertec Effect
- Portugal · Aelardis, Alostine
- Romania · Bilastină Gemax Pharma, Bilastină Msn
- Sweden · Bilacina, Bilastin Teva
- Slovenia · Bilador, Bilastin Stada
- Slovakia · Abisax, Bilastin Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d49a58e8-acb6-4652-bc33-22dbe634e6f7 GET /v1/drugs/d49a58e8-acb6-4652-bc33-22dbe634e6f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67280591",
"date_amm": "2018-03-16",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "BILASTINE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about bilastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.